Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Oct 2020 for Spruce Biosciences, INC., €3.2M.
Filing timeline
BuySaleMoghrabi Dina Chaya
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -72.5%Entry US$91,406.25 · Close at T+365 US$25,143.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Moghrabi Dina Chaya: trading record in brief
Moghrabi Dina Chaya is a declared insider of Spruce Biosciences, Inc., with filings sourced from SEC (Form 4). Activity is concentrated on a single trading day, 14 October 2020, with 2 filings.
The open-market record is one-sided, with 1 purchase worth €3.2M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 16 October 2020, the filings show an open-market purchase worth €3.2M in Spruce Biosciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Moghrabi Dina Chaya
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
250,000 shares@ US$15.00100.0% of flowCommon StockSEC:0001209191-20-055013:1
Canonical exit: 12 Jan 2021 (T+90)
1,911,022 sharesCommon StockSEC:0001209191-20-055013:0
2 of 2 declarations
